Opportunity ID: 318261

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-311
Funding Opportunity Title: Mechanisms of Tolerance (R21/R33 – Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 10, 2019
Last Updated Date: Jul 10, 2019
Original Closing Date for Applications: Jan 07, 2022
Current Closing Date for Applications: Jan 07, 2022
Archive Date: Feb 12, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
County governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
City or township governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) focuses on sensitivity and tolerance mechanisms underlying the development of alcohol use disorder. The intent of this FOA is to: (1) develop hypotheses about cellular, molecular or network mechanisms that regulate sensitivity and tolerance to alcohol, and (2) develop quantitative models to predict the development of tolerance and the progression to alcohol use disorder. These objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, clinical trial required, in which secondary data analysis or pilot studies can occur during the R21 phase, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R21 phase. Applicants interested in animal studies on the mechanisms of tolerance may consider FOA (PAR-18-659) or in the genetic basis of tolerance may consider FOA (PA-18-660).
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-311.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00252830 Sep 16, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00260079 Sep 16, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270262 Nov 16, 2021 Jan 07, 2022 View

Package 1

Mandatory forms

318261 RR_SF424_2_0-2.0.pdf

318261 PHS398_CoverPageSupplement_4_0-4.0.pdf

318261 RR_OtherProjectInfo_1_4-1.4.pdf

318261 PerformanceSite_2_0-2.0.pdf

318261 RR_KeyPersonExpanded_2_0-2.0.pdf

318261 RR_Budget_1_4-1.4.pdf

318261 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

318261 RR_SubawardBudget30_1_4-1.4.pdf

318261 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

318261 RR_SF424_2_0-2.0.pdf

318261 PHS398_CoverPageSupplement_5_0-5.0.pdf

318261 RR_OtherProjectInfo_1_4-1.4.pdf

318261 PerformanceSite_2_0-2.0.pdf

318261 RR_KeyPersonExpanded_2_0-2.0.pdf

318261 RR_Budget_1_4-1.4.pdf

318261 PHS398_ResearchPlan_4_0-4.0.pdf

318261 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

318261 RR_SubawardBudget30_1_4-1.4.pdf

318261 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

318261 RR_SF424_5_0-5.0.pdf

318261 PHS398_CoverPageSupplement_5_0-5.0.pdf

318261 RR_OtherProjectInfo_1_4-1.4.pdf

318261 PerformanceSite_4_0-4.0.pdf

318261 RR_KeyPersonExpanded_4_0-4.0.pdf

318261 RR_Budget_3_0-3.0.pdf

318261 PHS398_ResearchPlan_4_0-4.0.pdf

318261 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

318261 RR_SubawardBudget30_3_0-3.0.pdf

318261 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T20:50:57-05:00

Share This Post, Choose Your Platform!

About the Author: